News
An article featuring an interview was published on Nikkei Biotech Online.
An article featuring our company was published on Nikkei Biotech ONLINE on June 29, 2026. Please refer to the […]
Selected as a finalist for Science to Startup Japan
Radena Sciences, Inc. was selected as a finalist for "Science to Startup (S2S) Japan," sponsored by AN Venture […]
Selected as a pitching company for AMED Seeds Acceleration
Radena Sciences, Inc. has been selected to present at the AMED Seeds Acceleration Pitch, a stage event at the […]
Exhibiting at Japan Healthcare Venture Summit 2025
Radena Sciences, Inc. will be exhibiting at the Japan Healthcare Venture Summit 2025, which will be held at Pa […]
Selected for the acceleration program "Direct Flight"
Radena Sciences, Inc. has been selected for the Boston program of the acceleration program "Direct Flight" by […]
Selected for Rising Biotech Challenge 2025
Radena Sciences, Inc. has been selected for the "Rising Biotech Challenge 2025," a domestic biotech research s […]
Relocation of Head Office
The head office was relocated from Shinjuku-ku, Tokyo to Nihonbashi, Chuo-ku, Tokyo.
A proposal of Masayuki Nakamori (CSO) adopted for AMED research project
A proposal by Masayuki Nakamori, Professor of the Department of Neurology at Yamaguchi University, who also se […]
Selected for the startup support program of Tokyo Metropolitan Government
Radena Sciences, Inc. has been selected for the first startup support program in fiscal year 2023, implemented […]
New Chief Scientific Officer (CSO) Appointed
Professor Masayuki Nakamori of the Department of Neurology at Yamaguchi University was appointed as CSO of our […]